Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

Synergy CHC Corp.

Annual Report

Filed Apr 1, 2026Accepted Mar 31, 2026, 9:23 PM EDTCIK 1562733Accession 0001213900-26-037883
Share

Company context

We are a provider of consumer health care, beauty, and lifestyle products. Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any U.S. Food and Drug Administration (“FDA”) -approved investigational new drug (IND) application) that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals. Collectively, these brands are referred to as nutraceuticals. Our products are sold through some of the nation’s leading club, mass drug, and other retailers such as Costco, Amazon.com, Walmart, Walgreens, BJ’s, and The Vitamin Shoppe. Additionally, we have expanded into Canada and Mexico.

Current securities

Historical securities (1)

Recent company filings

  1. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingSep 16, 2026
  2. Bankruptcy or Receivership · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 8, 2026
  3. Triggering Events That Accelerate or Increase a Direct Financial ObligationAug 26, 2026
  4. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureAug 21, 2026
  5. Triggering Events That Accelerate or Increase a Direct Financial ObligationAug 11, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗